{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:38:23Z","timestamp":1790707103829,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/gco.0b013e32834feb6a","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T09:17:05Z","timestamp":1328865425000},"page":"78-83","source":"Crossref","is-referenced-by-count":22,"title":["Pregnancy complications in patients with epilepsy"],"prefix":"10.1097","volume":"24","author":[{"given":"Ingrid","family":"Borthen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1471-0528.2009.02354.x","article-title":"Complications during pregnancy in women with epilepsy: population-based cohort study.","volume":"116","author":"Borthen","year":"2009","journal-title":"BJOG"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4065\/71.6.576","article-title":"Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota.","volume":"71","author":"Hauser","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 9","key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1528-1157.2000.tb02211.x","article-title":"Epilepsy, pregnancy, and the child.","volume":"41","author":"Kaneko","year":"2000","journal-title":"Epilepsia"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1528-1167.2009.02147.x","article-title":"Pregnancy, delivery, and outcome for the child in maternal epilepsy.","volume":"50","author":"Veiby","year":"2009","journal-title":"Epilepsia"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajog.2003.09.020","article-title":"Epilepsy and pregnancy: an obstetric perspective.","volume":"190","author":"Richmond","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bmj.321.7262.674","article-title":"Population based, prospective study of the care of women with epilepsy in pregnancy.","volume":"321","author":"Fairgrieve","year":"2000","journal-title":"BMJ"},{"key":"R7-5-20210129","first-page":"856","article-title":"Pregnancy and epilepsy: what should we tell our patients J N","volume":"256","author":"Tomson","year":"2009","journal-title":"eurol"},{"issue":"Suppl 1","key":"R8-5-20210129","first-page":"1","article-title":"Saving mothers lives: reviewing maternal deaths to make motherhood safer - the eighth report of the confidential enquiries into maternal deaths in the United Kingdom.","volume":"118","author":"Cantwell","year":"2011","journal-title":"BJOG"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yebeh.2009.03.031","article-title":"Influences on seizure activity in pregnant women with epilepsy.","volume":"15","author":"Sabers","year":"2009","journal-title":"Epilepsy Behav"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1528-1167.2007.01412.x","article-title":"Seizure control in antiepileptic drug-treated pregnancy.","volume":"49","author":"Vajda","year":"2008","journal-title":"Epilepsia"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1212\/01.wnl.0000195888.51845.80","article-title":"Seizure control and treatment in pregnancy, observations from the EURAP epilepsy pregnancy registry.","volume":"66","year":"2006","journal-title":"Neurology"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"c6582","DOI":"10.1136\/bmj.c6582","article-title":"Carbamazepine in pregnancy.","volume":"341","author":"Nulman","year":"2011","journal-title":"BMJ"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(68)91781-9","article-title":"Anticonvulsant drugs and congenital abnormalities.","volume":"2","author":"Meadow","year":"1968","journal-title":"Lancet"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.yebeh.2009.04.026","article-title":"Antiepileptic drug use in women of childbearing age.","volume":"15","author":"Meador","year":"2009","journal-title":"Epilepsy Behav"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1651-2227.2004.tb00701.x","article-title":"Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study.","volume":"93","author":"Wide","year":"2004","journal-title":"Acta Paediatr"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1365-2125.2009.03544.x","article-title":"Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations.","volume":"68","author":"Matok","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1157.1998.tb01186.x","article-title":"Pregnancies of women with epilepsy: a population-based study in Iceland.","volume":"39","author":"Olafsson","year":"1998","journal-title":"Epilepsia"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogenicity of anticonvulsant drugs.","volume":"344","author":"Holmes","year":"2001","journal-title":"N Engl J Med"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Res"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/01.WNL.0000163771.96962.1F","article-title":"Antiepileptic drug use of women with epilepsy and congenital malformations in offspring.","volume":"64","author":"Artama","year":"2005","journal-title":"Neurology"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/11317640-000000000-00000","article-title":"Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies.","volume":"33","author":"Banach","year":"2010","journal-title":"Drug Saf"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.0013-9580.2004.451102.x","article-title":"North American antiepileptic drug pregnancy registry.","volume":"45","author":"Holmes","year":"2004","journal-title":"Epilepsia"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0967-5868(03)00158-9","article-title":"The Australian registry of antiepileptic drugs in pregnancy: experience after 30 months.","volume":"10","author":"Vajda","year":"2003","journal-title":"J Clin Neurosci"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1471-0528.2010.02694.x","article-title":"Delivery outcome of women with epilepsy: a population-based cohort study.","volume":"117","author":"Borthen","year":"2010","journal-title":"BJOG"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1528-1167.2010.02525.x","article-title":"Pregnancy registries: differences, similarities, and possible harmonization.","volume":"51","author":"Tomson","year":"2010","journal-title":"Epilepsia"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/00016340600604625","article-title":"Pregnancy, delivery, and neonatal complications after treatment with antiepileptic drugs.","volume":"85","author":"Pilo","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.seizure.2009.11.008","article-title":"Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study.","volume":"19","author":"Mawer","year":"2010","journal-title":"Seizure"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations.","volume":"362","author":"Jentink","year":"2010","journal-title":"N Engl J Med"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"c6581","DOI":"10.1136\/bmj.c6581","article-title":"Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.","volume":"341","author":"Jentink","year":"2010","journal-title":"BMJ"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"issue":"Pt 2","key":"R32-5-20210129","first-page":"396","article-title":"Foetal antiepileptic drug exposure and verbal versus nonverbal abilities at three years of age.","volume":"134","author":"Meador","year":"2010","journal-title":"Brain"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2011.624","article-title":"Newer-generation antiepileptic drugs and the risk of major birth defects.","volume":"305","author":"Molgaard-Nielsen","year":"2011","journal-title":"JAMA"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yebeh.2011.06.014","article-title":"Fetal antiepileptic drug exposure: motor, adaptive, and emotionalbehavioral functioning at age 3 years.","volume":"22","author":"Cohen","year":"2011","journal-title":"Epilepsy Behav"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch Dis Child"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.seizure.2009.09.002","article-title":"Population-based study of antiepileptic drug exposure in utero-Influence on head circumference in newborns.","volume":"18","author":"Almgren","year":"2009","journal-title":"Seizure"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1528-1167.2006.00386.x","article-title":"Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.","volume":"47","author":"Viinikainen","year":"2006","journal-title":"Epilepsia"},{"issue":"Suppl 8","key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.0013-9580.2004.458009.x","article-title":"Statistics on deliveries of mothers with epilepsy at Yokohama City University Hospital.","volume":"45","author":"Endo","year":"2004","journal-title":"Epilepsia"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/14767050500434096","article-title":"Pregnancy and perinatal outcome in epileptic women: a population-based study.","volume":"19","author":"Katz","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1007\/s00415-009-5222-3","article-title":"No increase in adverse pregnancy outcomes for women receiving antiepileptic drugs.","volume":"256","author":"Lin","year":"2009","journal-title":"J Neurol"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.seizure.2008.08.010","article-title":"Maternal and obstetric outcome of women with epilepsy.","volume":"18","author":"Thomas","year":"2009","journal-title":"Seizure"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1471-0528.2011.03004.x","article-title":"Obstetric outcome in women with epilepsy: a hospital-based, retrospective study.","volume":"118","author":"Borthen","year":"2011","journal-title":"BJOG"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2009.142","article-title":"Affect of seizures during gestation on pregnancy outcomes in women with epilepsy.","volume":"66","author":"Chen","year":"2009","journal-title":"Arch Neurol"},{"key":"R45-5-20210129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.seizure.2009.09.002","article-title":"Population-based study of antiepileptic drug exposure in utero: influence on head circumference in newborns.","volume":"18","author":"Almgren","year":"2009","journal-title":"Seizure"},{"key":"R46-5-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.0730-7659.2004.00301.x","article-title":"Effect of preexisting chronic disease on primary cesarean delivery rates by race for births in U.S. military hospitals, 1999-2002.","volume":"31","author":"Linton","year":"2004","journal-title":"Birth"},{"issue":"Suppl 1","key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1528-1167.2008.01964.x","article-title":"Italian consensus conference on epilepsy and pregnancy, labor and puerperium.","volume":"50","author":"Aguglia","year":"2009","journal-title":"Epilepsia"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e3181a6b2f8","article-title":"Practice parameter update: management issues for women with epilepsy, focus on pregnancy (an evidence-based review), obstetrical complications and change in seizure frequency - report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"R50-5-20210129","first-page":"1691","article-title":"Women and epilepsy.","volume":"123","author":"Tauboll","year":"2003","journal-title":"Tidsskr Nor Laegeforen"},{"key":"R51-5-20210129","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0002-9378(85)90615-5","article-title":"Obstetric outcome in women with epilepsy.","volume":"152","author":"Hiilesmaa","year":"1985","journal-title":"Am J Obstet Gynecol"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GCO.0b013e32834feb6a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:17:56Z","timestamp":1620951476000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001703-201203000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e32834feb6a","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}